Alto Neuroscience, Inc. Common Stock (ANRO)
EBITDA Growth
-59.63%
Quarterly · Period ending:
ANRO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-59.63%period ending
Latest reported-59.63%period ending
ANRO Quarterly EBITDA YoY % (-42.54% → -59.63%)
Year-over-year change
High-resolution chart · PNG
ANRO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -59.6294% | |
| -77.1389% | |
| -5.1163% | |
| 18.0542% | |
| -8.4843% | |
| -10.9912% | |
| -36.4844% | |
| -87.1715% | |
| -89.3239% | |
| -88.7402% | |
| -42.5414% |